Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression
about
Structure and Functional Diversity of GCN5-Related N-Acetyltransferases (GNAT)The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic targetKATs in cancer: functions and therapiesTherapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseasesAlgorithms for network-based identification of differential regulators from transcriptome data: a systematic evaluationUSP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 proteinInhibition of histone H3K9 acetylation by anacardic acid can correct the over-expression of Gata4 in the hearts of fetal mice exposed to alcohol during pregnancy.MYC cofactors: molecular switches controlling diverse biological outcomes.The bromodomain of Gcn5 regulates site specificity of lysine acetylation on histone H3α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration.Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching.GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways.Acetylation of C/EBPα inhibits its granulopoietic function.A novel miR-200b-3p/p38IP pair regulates monocyte/macrophage differentiation.CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung CancerHistone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expressionKAT5 silencing induces apoptosis of GBC-SD cells through p38MAPK-mediated upregulation of cleaved Casp9.HDAC10 promotes lung cancer proliferation via AKT phosphorylation.Regulatory variation: an emerging vantage point for cancer biology.Functions of SAGA in development and disease.Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation.KATapulting toward Pluripotency and Cancer.Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A.Cyclin D1 expression in Bowen's disease and cutaneous squamous cell carcinomaMotifs in the amino-terminus of CENP-A are required for its accumulation within the nucleus and at the centromereDifferential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma CellsStudy on Inhibitory Effect of MaiMenDong Decoction and WeiJing Decoction Combination with Cisplatin on NCI-A549 Xenograft in Nude Mice and Its Mechanism.The Histone Acetyltransferase GCN5 Expression Is Elevated and Regulated by c-Myc and E2F1 Transcription Factors in Human Colon Cancer.Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients.Acetylome profiling reveals overlap in the regulation of diverse processes by sirtuins, gcn5, and esa1.Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer.The histone acetylation mediated by Gcn5 regulates the Hoxc11 gene expression in MEFs.Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.Increased lysyl oxidase-like 2 associates with a poor prognosis in non-small cell lung cancer.The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1
P2860
Q26314426-7FC28789-F6D4-4971-862C-5F251563265AQ26744292-06359D94-3F69-443C-B57F-C0491CCF5894Q26859355-A51D3964-64EB-476D-89CF-46363D26CD40Q28071309-116FDA22-A23D-4B1F-9A6F-6D7303EB717CQ30862457-243D47F9-A334-490C-8DD7-554A2BA7DC74Q33779463-B0D148B9-8104-4122-A6E2-042A6CB8AB55Q34015565-A264183C-939C-49DF-B407-D9E4677609DEQ34083178-AEACDEDB-95BF-435B-BACC-7283E8317D56Q34468312-BB15C65D-1A78-4690-90D6-668B347D435CQ35151075-C6D919F5-0E77-4E4C-A965-B42AD7531708Q35220027-732EAD26-1192-44C5-AE97-43932AF6C5ECQ36184181-FA2DF7C0-A619-4853-B16F-418AC63650F6Q36747244-31E8B72B-F537-4B23-AE7C-CABC5040649CQ36883162-17B1E872-3CA6-4B77-90AB-BE296F0B1253Q37067977-74406247-742F-4D7D-8DA7-EA5484E43FC7Q37144686-41938734-8854-48D6-90DE-CC4D98067D1AQ37452157-7F65EB04-84DB-4E1A-8A14-636A0322ED9CQ37644872-410260B7-DE3F-463D-A03F-8C04D67C2227Q38164307-610E6FD7-276B-4377-8C03-547DDCD96FC7Q38238829-9CA5A767-CB04-4052-83F5-4BCEF9A95388Q38379487-13A2524E-C1B2-42F2-AE2D-73F888436975Q38976614-3DB2C778-5A6B-44C0-8C99-DDEEB79CD015Q39011776-359C7703-AC77-4F92-95A1-E09E99F4CA9AQ40514940-AD91DE67-BE55-4B84-9E51-E8E686CECEE8Q41092324-995EFB1A-D469-499F-8028-AFE94F683042Q41182202-B7351F97-22F4-4B9B-B546-5D20B16E5AB6Q41243431-A36E0C7E-D390-4D99-88B0-2096DC2D157BQ41614744-FE22D416-F99A-4E87-A534-F0440979EB65Q41636426-B3B260D7-26FB-4F50-8B4D-8A30974EBD0FQ41885791-482C58BF-1B3E-4CD2-95AB-496BF59F4D74Q48907560-415ECF38-427F-403A-B256-605CA7EEE0EBQ50625042-6C10E0AC-CF33-4386-B2B7-10EA6E3E44FDQ50670538-F736B356-FA75-419C-A2C4-8938EAA410FEQ51319814-360C4546-4945-48F5-980D-0B4ED25794E3Q58798155-DE7F3613-F327-4FB8-B623-E5604C96E691
P2860
Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lysine acetyltransferase GCN5 ...... n D1, and cyclin E1 expression
@en
type
label
Lysine acetyltransferase GCN5 ...... n D1, and cyclin E1 expression
@en
prefLabel
Lysine acetyltransferase GCN5 ...... n D1, and cyclin E1 expression
@en
P2093
P2860
P356
P1476
Lysine acetyltransferase GCN5 ...... n D1, and cyclin E1 expression
@en
P2093
Anmei Deng
Guiying Wang
Jiuhong Kang
Qianqian Wang
Songcheng Zhu
Tingyi Wei
Xiaoxing Si
P2860
P304
14510-14521
P356
10.1074/JBC.M113.458737
P407
P577
2013-03-29T00:00:00Z